SCHEMBL14508202

SCHEMBL14508202

CC1(C)c2cc(-c3ccc4c(c3)C(C)(C)c3cc(-c5ncccn5)ccc3-4)ccc2-c2ccc(-c3ccc4c(c3)C(C)(C)c3cc(-c5cc(-c6ccccc6)ccc5-c5ccccc5)ccc3-4)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 4/20 0.38
▸ RARB P10826 1/20 0.36
▸ RARG P13631 1/20 0.36
▸ RXRA P19793 1/20 0.36
▸ CLK4 Q9HAZ1 2/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ TNKS O95271 5/20 0.35
▸ TNKS2 Q9H2K2 2/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ APAF1 O14727 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ XBP1 P17861 1/20 0.34
▸ PTBP1 P26599 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ GALK1 P51570 1/20 0.34
▸ BLM P54132 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14508215 0.96 PDK2 (0.41) PDK2RARBRARGRXRACLK4
SCHEMBL14508236 0.95 PDK2 (0.42) PDK2RARBRARGRXRACLK4
SCHEMBL14508212 0.94 RARB (0.41) PDK2RARBRARGRXRACLK4
SCHEMBL14508155 0.90 PDK2 (0.40) PDK2RARBRARGRXRA
SCHEMBL14508195 0.90 PDK2 (0.40) PDK2RARBRARGRXRA
SCHEMBL14508289 0.90 PDK2 (0.41) PDK2RARBRARGRXRAMEN1
SCHEMBL14508219 0.90 CLK4 (0.41) PDK2RARBRARGCLK4DYRK1A
SCHEMBL14508213 0.90 CLK4 (0.41) PDK2RARBRARGCLK4DYRK1A
SCHEMBL14508200 0.90 PDK2 (0.40) PDK2RARBRARGCLK4DYRK1A
SCHEMBL14508235 0.90 PDK2 (0.40) PDK2RARBRARGRXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070122652-A1 Compound and organic electroluminescent device using same CANON KABUSHIKI KAISHA (JP) 2007-05-31 — — US disclosed
US-20070122652-A1 Compound and organic electroluminescent device using same CANON KABUSHIKI KAISHA (JP) 2007-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070122652-A1 Compound and organic electroluminescent device using same OR10J3, LEF1, RPL19 PDK2 3230/4885RARB 2426/4885RARG 3161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback